About Us - Privacy Policy - Disclaimer - Contact Us - Editorial & Sponsorship Policy     
Lymphoma Innovations

Targeted Information for
Patients With
Non-Hodgkins Lymphoma


Our Bloggers:

 
 

 
   

     

« More On Excuses | Main | News You Can Use! »

What will be the response?

Yesterday, I spoke with a neighbor who told me that his friend in the Northeast has just been diagnosed with non-Hodgkin's lymphoma.

I was pleased to have been told that the friend will ask his medical oncologist about radioimmunotherapy (RIT) and its potential appropriateness to his specific condition.

Personally, I was thinking to myself: Will the response will be something like, "RIT is interesting, but we need more data"? Data is the "Holy Grail" in
medicine. Data is important, but it can be used in an unseemly manner to
pevent patients from receiving a medication that is appropriately indicated.

Oncologists are well-trained, good people. But, they can be biased; at times, they seem to
only want their patients to receive therapy that they, themselves, administer.
(medical oncologists do not administer RIT.)


Mort